Test Directory

Test Code
INFXP
Test Name
Infliximab Quantitation with Antibodies to Infliximab, Serum
CPT Codes
80230, 82397
Included Tests
  • Infliximab
  • Infliximab Ab
  • Interpretation
Expected Turnaround Time
3 - 6 days
Clinical Utility

This test is useful for evaluating patients for loss of response, partial response on initiation of therapy, autoimmune or hypersensitivity reactions, primary nonresponse, reintroduction after drug holiday, endoscopic/computed tomography enterography recurrence (in inflammatory bowel disease), acute infusion reactions and proactive monitoring.

When this test is ordered, infliximab quantitation and testing for antibodies to infliximab will always be performed.

Specimen and Container Info

Specimen Type: Serum

Preferred Collection Container: Red Top, Plain

Alternate Collection Container: Gold Top, Serum Separator

Desired Specimen Volume: 1.2 mL

Collection Instructions
  1. Collect a red top, plain tube via venipuncture.
  2. Draw blood immediately before next scheduled dose (trough specimen).
Processing and Submission Instructions
  1. Separate serum from cells with 2 hours of collection.
  2. Transfer 1.2 mL of serum to a clear aliquot tube (screw cap).
Patient Preparation

For 12 hours before specimen collection, patient should not take multivitamins or dietary supplements (eg, hair, skin, and nail supplements) containing biotin (vitamin B7).

Transport Instructions

Transport to the laboratory refrigerated.

Stability Requirements

Refrigerated

28 days

Frozen

28 days

Causes for Rejection
  • Gross hemolysis
  • Gross icterus
  • Heat-Treated
Methodology
Selective Reaction Monitoring Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) | Electrochemiluminescent Bridging Immunoassay with Acid Dissociation
Reference Intervals

See patient report.

Limitations

These assays do not differentiate between the originator and biosimilar products.

Samples containing more than 12.5 ng/mL biotin (vitamin B7) may interfere (in the form of depressed signal) with Infliximab Antibodies.

Alternate Names
  • Infliximab Antibodies
  • REMICADE
  • AVSOLA
  • Inflectra
Reference Lab
Mayo Clinic Laboratories
Testing Schedule
Varies